Načítá se...
Exploiting the CRISPR‐Cas9 gene‐editing system for human cancers and immunotherapy
The discovery of clustered regularly interspaced short palindromic repeats and CRISPR‐associated protein 9 (CRISPR‐Cas9) technology has brought advances in the genetic manipulation of eukaryotic cells, which has revolutionised cancer research and treatment options. It is increasingly being used in c...
Uloženo v:
| Vydáno v: | Clin Transl Immunology |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8219901/ https://ncbi.nlm.nih.gov/pubmed/34188916 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cti2.1286 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|